Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03
Carcinoma, Squamous Cell
Head and Neck Neoplasms
AQUA LOX expression was strongly associated with increased metastasis, progression, and death in RTOG 90-03 patients. This study validates that LOX is a marker for metastasis and survival in HNC.
PubMed Central ID
Digital Object Identifier (DOI)
Additional Document Info
has global citation frequency